| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |